International Liver Cancer Incidence Trends—Letter | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

International Liver Cancer Incidence Trends—Letter

Cancer Epidemiol Biomarkers Prev (2012) 21 (2): 384–385.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib

S. Colagrande
L. Calistri
C. Campani
G. Dragoni
C. Lorini
C. Nardi
A. Castellani
F. Marra

European Radiology (2021) 31 (3): 1608.

Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12

Tuvshinjargal Chimed
Tuvshingerel Sandagdorj
Ariana Znaor
Mathieu Laversanne
Badamsuren Tseveen
Purevsuren Genden
Freddie Bray

International Journal of Cancer (2017) 140 (2): 302.

Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma

Bo Zhu
Shaobo Chen
Xiaoding Hu
Xiaofeng Jin
Yichen Le
Lihuan Cao
Zhonghua Yuan
Zhen Lin
Songmin Jiang
Lichun Sun
Long Yu

Neoplasia (2017) 19 (7): 583.

Overexpression of syntenin enhances hepatoma cell proliferation and invasion: Potential roles in human hepatoma

XUEMIN LIU
XUFENG ZHANG
YI LV
JUNXI XIANG
JIANHUA SHI

Oncology Reports (2014) 32 (6): 2810.

CYP2E1 RsaI/PstI Polymorphism and Liver Cancer Risk among East Asians: a Huge Review and Meta-analysis

Zhong Tian
Yi-Ling Li
Lin Zhao
Chen-Liang Zhang

Asian Pacific Journal of Cancer Prevention (2012) 13 (10): 4915.